san

Novotech Earns Frost & Sullivan’s 2025 Global Company of the Year Recognition for Excellence in Biotech Clinical Research Services

Recognized for its biotech-first focus, innovation in clinical trial delivery, and best-in-class client experience, Novotech sets the global standard in…

17 hours ago

The Ensign Group Purchases Skilled Nursing Facility in Texas

July 02, 2025 06:00 ET  | Source: The Ensign Group, Inc. SAN JUAN CAPISTRANO, Calif., July 02, 2025 (GLOBE NEWSWIRE)…

2 days ago

The Ensign Group Continues Growth in Idaho

July 02, 2025 06:00 ET  | Source: The Ensign Group, Inc. SAN JUAN CAPISTRANO, Calif., July 02, 2025 (GLOBE NEWSWIRE)…

2 days ago

Belite Bio Announces Completion of Enrollment in the Pivotal Global Phase 3 PHOENIX Trial Evaluating Oral Tinlarebant in Geographic Atrophy

July 02, 2025 03:00 ET  | Source: Belite Bio, Inc -  500 subjects enrolled across the United States, the United…

2 days ago

AN Venture Partners Announces Final Close of $200M Fund I

One of the largest Japan focused biotech funds to dateSAN FRANCISCO & TOKYO--(BUSINESS WIRE)--AN Venture Partners (ANV), a global biotech…

2 days ago

Ameresco Receives Frost & Sullivan’s 2025 Global Company of the Year Award for Excellence in Energy Services

Recognized for customer-centric innovation, strategic execution, and leadership in flexible, turnkey energy solutions worldwide SAN ANTONIO, July 1, 2025 /PRNewswire/…

2 days ago

Siemens Receives Frost & Sullivan’s 2025 Europe, Middle East, and Africa Company of the Year Award for Excellence in Smart Water Meter Data Management

Siemens sets the benchmark in innovation and customer impact, helping utilities digitalize their operations and improve sustainable water management across EMEA…

2 days ago

The Ensign Group, Inc. Announces Retirement of Its Executive Chairman

June 20, 2025 16:30 ET  | Source: The Ensign Group, Inc. SAN JUAN CAPISTRANO, Calif., June 20, 2025 (GLOBE NEWSWIRE)…

2 weeks ago

Verdiva Bio to Present New Data Highlighting Once-Weekly Potential of Its Investigational Oral Obesity Candidates at the ADA 85th Scientific Sessions

Phase 1 data evaluating VRB-101, Verdiva Bio’s cAMP-biased oral GLP-1RA, provides proof of concept for potential once-weekly oral administration. Preclinical…

2 weeks ago

Structure Therapeutics Announces Two Late-Breaking Poster Presentations at the American Diabetes Association 85th Scientific Sessions Including New Preclinical Data for Oral Small Molecule Amylin Agonist, ACCG-2671

June 20, 2025 19:30 ET  | Source: Structure Therapeutics Inc. SAN FRANCISCO, June 20, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics…

2 weeks ago